Charles L. Shapiro
- Oncology top 0.1%
- Molecular Biology top 2%
- Cancer Research top 0.5%
- Pulmonary and Respiratory Medicine top 1%
- Radiology, Nuclear Medicine and Imaging top 1%
- Co-authors
- Abram RechtBhuvaneswari RamaswamyMeryl S. LeBoffBarbara L. AndersenJudith ManolaWilliam E. CarsonSarmila MajumderConstance Cirrincione
- Topics
- Cancer Treatment and Pharmacology (53 papers)Breast Cancer Treatment Studies (31 papers)Bone health and treatments (30 papers)
- Partner nations
- United StatesCanadaTaiwan
In The Last Decade
Charles L. Shapiro
228 papers receiving 12.8k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Oncology 7.3k
- Molecular Biology 3.8k
- Cancer Research 2.9k
- Pulmonary and Respiratory Medicine 2.2k
- Radiology, Nuclear Medicine and Imaging 1.1k
Countries citing papers authored by Charles L. Shapiro
This map shows the geographic impact of Charles L. Shapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles L. Shapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles L. Shapiro more than expected).
Fields of papers citing papers by Charles L. Shapiro
This network shows the impact of papers produced by Charles L. Shapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles L. Shapiro. The network helps show where Charles L. Shapiro may publish in the future.
Co-authorship network of co-authors of Charles L. Shapiro
This figure shows the co-authorship network connecting the top 25 collaborators of Charles L. Shapiro. A scholar is included among the top collaborators of Charles L. Shapiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles L. Shapiro. Charles L. Shapiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 49 | |
| 4 | 20 | |
| 5 | 107 | |
| 6 | 124 | |
| 7 | 147 | |
| 8 | 29 | |
| 9 | 96 | |
| 10 | 152 | |
| 11 | Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathybreakdown → | 718 |
| 12 | 162 | |
| 13 | 52 | |
| 14 | 54 | |
| 15 | 32 | |
| 16 | Piwil2 is expressed in various stages of breast cancers and has the potential to be used as a novel biomarker. | 80 |
| 17 | 446 | |
| 18 | 153 | |
| 19 | 21 | |
| 20 | 92 |
About Charles L. Shapiro
Charles L. Shapiro is a scholar working on Oncology, Cancer Research and Orthopedics and Sports Medicine, having authored 233 papers that have together received 13.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (53 papers), Breast Cancer Treatment Studies (31 papers) and Bone health and treatments (30 papers). The work is most often cited by research in Oncology (7.3k citations), Cancer Research (2.9k citations) and Orthopedics and Sports Medicine (845 citations). Charles L. Shapiro has collaborated with scholars based in United States, Canada and Taiwan. Frequent co-authors include Abram Recht, Bhuvaneswari Ramaswamy, Meryl S. LeBoff, Barbara L. Andersen, Judith Manola, William E. Carson, Sarmila Majumder, Constance Cirrincione, Electra D. Paskett and Satavisha Roy. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.